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BACKGROUND: Urogenital symptoms affect up to half of
women after menopause, but their impact on women’s
day-to-dayfunctioningandwellbeingis poorlyunderstood.
METHODS: Postmenopausal women aged 45 to 80 years
reporting urogenital dryness, soreness, itching, or pain
during sex were recruited to participate in in-depth focus
groups to discuss the impact of their symptoms. Focus
groups were homogenous with respect to race/ethnicity
and stratified by age (for White or Black women) or
language (for Latina women). Transcripts of sessions
were analyzed according to grounded theory.
RESULTS: Six focus groups were conducted, involving
44 women (16 White, 14 Black, 14 Latina). Five domains
of functioning and wellbeing affected by symptoms were
identified: sexual functioning, everyday activities, emo-
tional wellbeing, body image, and interpersonal relations.
For some participants, symptoms primarily affected their
a b i l i t yt oh a v ea n de n j o ys e x ,a sw e l la sb er e s p o n s i v et o
their partners. For others, symptoms interfered with
everyday activities, such as exercising, toileting, or
sleeping. Participants regarded their symptoms as a sign
that they were getting old or their body was deteriorating;
women also associated symptoms with a loss of woman-
hood or sexuality. Additionally, participants reported
feeling depressed, embarrassed, and frustrated about
their symptoms, and expressed reluctance to discuss
them with friends, family, or health care providers.
CONCLUSIONS: Urogenital symptoms can have a
marked impact on sexual functioning, everyday activi-
ties, emotional wellbeing, body image, and interperson-
al relations after menopause. Clinicians may need to
question women actively about these symptoms, as
many are reluctant to seek help for this problem.
KEY WORDS: urogenital atrophy; vaginal dryness; dyspareunia;
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INTRODUCTION
The postmenopausal years are characterized by profound
degenerative and inflammatory changes in the urogenital
tissues, collectively described as urogenital atrophy
1.I nu pt o
half of women, these changes are accompanied by symptoms
such as dryness, soreness, itching, and pain during sexual
intercourse that can persist for many years after menopause,
causing ongoing discomfort and distress as women age
2–6.
Currently,theimpactofurogenitalatrophysymptomsonquality
of life after menopause is poorly understood. A few studies
conducted primarily in Europe have suggested that these symp-
toms may contribute to problems with sexual activity, body image,
and psychological wellbeing
7–10.T h e s es t u d i e sh a v el a r g e l yb e e n
confined to white women; however, even though epidemiologic
researchsuggeststhesesymptomsareequallyifnotmoreprevalent
in women of other racial/ethnic backgrounds
3,11, and even though
women’s experiences of these symptoms may be influenced
by cultural attitudes toward aging and urogenital function
12–14.
To address these issues, we conducted a qualitative study of
racially and ethnically diverse postmenopausal women experi-
encing urogenital dryness, soreness, itching, and pain with
sexual intercourse. Our goal was to identify dimensions of
functioning and wellbeing affected by urogenital atrophy symp-
toms, in order to guide future efforts to reduce their impact on
quality of life. We also sought to understand women’sb e l i e f s
about the etiology of their symptoms, attitudes toward discuss-
ing symptoms, and strategies for coping with symptoms, in
order to understand how these beliefs and attitudes might
influence their discussions with health care providers.
METHODS
Eligibility and Recruitment
Postmenopausal women aged 45 to 80 years from three racial/
ethnic groups (White, Black, and Latina) who reported uro-
genital symptoms were recruited to participate in focus group
discussions. Women were considered postmenopausal if they
had not had a menstrual period in 12 months; those who had
undergone hysterectomy were also required to have had
bilateral oophorectomy unless they were over 70 years of age.
In addition, to be eligible, women had to report moderate-to-
severe urogenital dryness, soreness, itching, or pain/discom-
fort during sex for at least 6 months.
Participants were recruited through newspaper notices and
brochure postings in primary care and gynecology offices.
This study was supported by grant P30AG15272 from the National
Institute of Aging; grant RR024130 from the National Center for Research
Resources at the National Institutes of Health; the Mt. Zion Health Fund;
and Bionovo, Inc. This paper was presented at the Society for General
Internal Medicine national meeting in Miami, Florida, on May 14, 2009.
Received May 6, 2009
Revised September 8, 2009
Accepted September 17, 2009
Published online November 12, 2009
45Women who had participated in other women’s health studies in
the San Francisco Bay Area
15,16 and expressed willingness to be
contacted for other research were also invited to participate.
Eligibility was determined through a screening telephone call,
after which eligible women were invited to participate in a semi-
structured discussion group with 6 to 10 other women.
Focus Groups
Six focus groups were conducted between April, 2007 and April,
2008 on the University of California, San Francisco campus. Each
group was homogenous with respect to race/ethnicity (White,
B l a c k ,o rL a t i n a ) .F o c u sg r o u p sw e r ea l s os t r a t i f i e db ye i t h e ra g e
(<60 versus ≥60 years old for White or Black women) or language
(English-speaking versus Spanish-speaking for Latina women).
Focus groups were led by female moderators who were
matched with respect to race/ethnicity, language, and general
age with participants. Moderators were trained in interviewing
and/or discussion moderation but were not clinicians. Focus
group sessions were audiotaped with the participants’ permis-
sion, and all sessions were directly observed by at least two
investigators from behind a one-way mirror. All participants
gave informed consent before their focus group.
Moderator guides were developed that encouraged women to
freely express their thoughts on how urogenital symptoms affected
their day-to-day activities, feelings, and relationships, using
prompts derived from a review of existing studies of genitourinary
conditions (Box 1). Additionally, moderators encouraged women to
discuss their thoughts about the etiology of symptoms, attitudes
toward discussing symptoms, and strategies for coping with
symptoms in everyday life. At the end of each session, participants
completed brief questionnaires assessing demographic and clini-
cal characteristics. Participants were offered $40 compensation
and reimbursement for costs of transportation or parking.
Data Analysis
Focus group recordings were transcribed and, if necessary,
translated into English by experienced bilingual transcription-
ists. Transcripts were then analyzed according to grounded
theory, a qualitative data analysis approach in which analysis
codes and explanatory themes are allowed to emerge from the
data
17. Additionally, the constant comparative approach was
used, in which codes identified in the first transcript (White
women ≥60 years of age) were applied to subsequent tran-
scripts, and additional codes were added as additional themes
emerged from the data
18.
To minimize bias in analyses, two methods of triangulation
were used: investigator triangulation (multiple investigators
attended the focus groups and reviewed transcripts) and
disciplinary triangulation (investigators represented different
areas of expertise). Specifically, transcripts were independently
read and coded by three members of the investigative team,
including a nurse practitioner specializing in women’s health,
a PhD-trained researcher experienced in quality-of-life assess-
ment, and a general internist with a research focus in
menopause. Afterwards, investigators met to discuss and
resolve differences in coding. Through this iterative process, a
set of common themes observed throughout the groups was
extracted and agreed upon by all investigators.
Additionally, semi-quantitative methods were used to ex-
plore potential differences in the impact of symptoms among
women of different age and/or race/ethnicity. Consistent with
other qualitative studies
19, we examined the frequency with
which various participant responses corresponding to different
coded themes occurred in each focus group session. All study
procedures were approved by the institutional review board at
the University of California San Francisco.
RESULTS
The mean (SD) age of participants was 58 (8) years, with a
range of 48 to 75 years (Table 1). The most commonly reported
urogenital symptom was dryness (66%), followed by soreness
(41%), pain/discomfort during sexual intercourse (41%), and
itching (36%).
Five major dimensions of functioning and wellbeing affected
by symptoms were identified through analysis— sexual func-
tioning, everyday activities, emotional wellbeing, self-concept/
body image, and interpersonal relations (Table 2). With the
exception of the everyday activities dimension, which did not
emerge in discussion among Black women under 60 years of
age, all dimensions featured prominently in discussion in all
six focus groups.
Sexual Functioning
Participants from all age, racial/ethnic, and language groups
described significant problems with sexual activity as a result
of their symptoms (Box 2). Some women who had previously
enjoyed active, satisfying sexual lives reported that their
symptoms had caused them to lose interest in sex: “[I]n the
last year I have only had sex twice, and both times it was
extremely painful, I can remember screaming in pain.... I
always loved sex, but... that is enough to disenchant me....
Because it’s too painful.” Some women who remained sexually
Box 1.  Sample Moderator Prompts to Promote Focus Group Discussion 
• In what ways have your vaginal symptoms affected or changed your day-to-day 
life? 
• Do your vaginal symptoms affect how physically active you are or the amount or 
type of exercise you do? How so? 
• Do you think your vaginal symptoms have changed how you feel about your life?  
Can you give an example? 
• Do you think you have changed how often you have sex or how you have sex as a 
result of your symptoms? 
• Have your vaginal symptoms affected your relationship with your spouse or 
partner?  If so, how? 
• Do you think your vaginal symptoms have affected your mood day-to-day?  If so, 
how? 
• How often do you find that you end up thinking about your vaginal symptoms in 
the course of a week?   
• What are the ways in which your vaginal symptoms have affected your romantic 
and sexual relationships? 
• What has changed about you as a person, if anything, since you developed these 
vaginal symptoms?  
• Has your attitude toward your health changed since you developed these 
symptoms?  If so, how? 
• Were you surprised when you developed these vaginal symptoms, or did you 
expect to develop them? 
• Do you think that having these symptoms has affected your relationship to friends 
or relatives other than your husband or sexual partner?  If so, how? 
• Have you ever talked about your symptoms with doctors, nurses, or other health 
care professionals about your symptoms? 
• Have you ever talked about your symptoms with friends or family members?  
Can you tell me about some of those conversations?  
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vaginal intercourse into a primarily painful experience: “And
sometimes you do it anyways, putting up with the discomfort,
the pain, but you wish that the moment would pass... because
you can’t stand it!... Instead of having pleasure, instead of
satisfaction, what you have is anguish, for it to be over.”
Box 2.  Participant Responses Regarding the Impact of Urogenital Symptoms on 
Dimensions of Functioning and Wellbeing 
Sexual 
functioning 
 “I am married now, and I just feel sorry for my husband, because I just don’t 
want to have sex anymore…. [It’s] painful. Extremely painful. And… it 
makes me feel like I am not a good wife.”  
“[W]ith oral sex… there is a response that promotes lubrication, and then you 
can have sex, and it’s not very painful.  It’s not very comfortable, but it’s not 
very painful.  But if there is not that preamble of oral sex, it’s impossible, it’s 
too painful.” 
“Then you worry… slipping in the KY Jelly, if it’s going to be lubricated 
enough so that you can get pleasure, and he can get pleasure, and stop him 
saying, ‘What’s going on here, you’re just a little too dry, so I can’t do 
anything?’”   
Everyday 
activities 
“It does interfere with your day-to-day life, because it doesn’t say, ‘Now, I 
am not going to bother you now because you’re around your friends or you’re 
around other people,’ you know.  You have to excuse yourself and go to the 
bathroom, and then there is nothing in there to give you any relief.”   
“I would feel that terrible burning so much that I couldn’t sleep at night.  It 
was a terrible burning, and I would go to the bathroom, I would put really 
cold water on myself, good and cold.  But I would feel that I couldn’t sleep, 
until almost one or two o’clock in the morning [when] I would fall asleep, 
when that pain would go away a little bit.”  
“[T]he more water you drink, the more you go, and the more you go, you 
have to wipe.  And if you don’t have the wipes with you, you have to wet the 
toilet tissue, or paper towel… I remember a time when I was irritated so bad... 
I had to hurry, get up, and go to the restroom, wet me a paper towel, and try to 
cool down... Oh, gee, it’s just, just irritating!  Really irritating!” 
Emotional 
wellbeing 
“I think with me… it may be because [I have] health problems already, and 
when [vaginal dryness] happens it’s one more thing, as far as pain and things 
like that to deal with.  And that’s why I know at times I do get depressed 
because, I think, I can’t have just one thing on my body that is just OK?”  
 “When I go to the bathroom and there’s, whatever, itching, dryness, burning, 
I have to remember that, okay, on the larger scale of things, [I’m] pretty damn 
lucky.  But, you know, as with anything else, I’m human, I have my weak 
moments, and I can sit there and feel sorry for myself and have a pity party.” 
Self-concept & 
body image 
“I’ve always had a pretty good feeling about myself, my self-image…  But as 
those symptoms became more obvious, I felt that three letter word, OLD, and 
that it put me in the category of being invisible.”  
“[W]hen you pass 50, you start looking back at the 20 year-olds, and saying 
OK… we know they don’t itch.… [N]ow I am 66, and I am not young 
anymore. I am not young anymore…. [N]ow I wish I didn’t have to get older, 
but the alternative to getting old is to die….”   
“I think [that] as you get older… the dryness is going to stay there, get worse.  
Everything is going to get worse as you get older.… You might have other 
things to get in your head to tone it down.  But it’s going to be there.  It’s 
going to be there on the backburner.”  
Interpersonal 
relations & 
communication 
“So when I started to suffer these things, I was embarrassed to tell even my 
female doctor, right?  There are things that you deal with yourself, trying to 
cure them alone, without help from anyone, and it’s terrible.  Now that I feel 
more confident with my doctor, I’ve talked to her, [but] it wasn’t very long 
ago, it’s only been a few months since I was able to tell my doctor.” 
“Yes, since it’s very private, it’s something that... nobody talks about.  Not 
the neighbor, nor at school, nor at work.  So then you think it’s something 
special that you are going through.”   
“On many occasions I had the intention to sit down with my husband… and 
talk to him about what I felt each time we had sexual contact, but he liked to 
joke a lot, he really liked to joke around, and I was embarrassed to tell him.  I 
said to myself, ‘He’s going to make jokes about what I am telling him.’” 
Participants who were involved in long-term sexual relation-
ships expressed concern about being unable to be responsive
to their partners as a result of their symptoms: “And I also feel
very guilty vis-à-vis my husband.... He likes to make love all
the time, but... I have been avoiding it... because it’s uncom-
fortable, it’s painful... and I don’t want to make him aware that
I have been avoiding it.” Participants described furtively
applying vaginal lubricants or trying to disguise their discom-
fort to prevent their partners from becoming aware of their
problem. Some participants also reported that their problems
with pain were exacerbated by the sexual problems of their
partners. For example, several women complained that their
need to apply lubricants made it difficult for them to respond
quickly on those occasions that their partners were able to
overcome their erectile dysfunction: “He’s at the age where, if it’s
working, we’re supposed to drop everything.... [I]nevitably when
the mood hits him, I’m not ready with the AstroGlide, or it’sf a r
away, and I’m going, ‘oh, please... give me a little notice.’”
Among women who were not currently involved in a sexual
relationship, some indicated that they would be reluctant to
enter into a new relationship due to fear of pain during sex:
“[M]y boyfriend is 15 years older than I am, and... he’si n
assisted living now... so it isn’t a problem at this moment. But I
worry, my God, if something happens to [him], and should I
find another boyfriend...would I say, “’No, I can’t do it.’?” Even
when women were capable of feeling desire for a new partner,
some said they were reluctant to progress to intercourse due to
fear of pain: “[S]ometimes I go out on a date, and you know,
you could consider me a teaser, ‘cause I still get the build up
and the desire to want to have sex, but I am not going to put
myself through the discomfort that I think I would suffer if I
had it.”
Everyday Activities
Although some participants indicated that their symptoms
were problematic only during sex, others said their symptoms
Table 1. Demographic and Clinical Characteristics of Participants
Characteristic Participants (N=44)
Race/ethnicity
White/Caucasian 16 (36%)
Black/African-American 14 (32%)
Latina/Hispanic 14 (32%)
Age
Total age range (yrs) 48, 75
Age > 60 yrs 17 (39%)
Primary language
English 36 (82%)
Spanish 8 (18%)
Relationship history
Sexually active
a 23 (52%)
Married/living with partner 17 (39%)
Work/education history
High school graduate 38 (86%)
Full- or part-time employed 19 (43%)
Medical/surgical history
Fair/poor self-reported health 18 (41%)
Hysterectomy 10 (23%)
Bilateral oophorectomy 9 (20%)
Moderate-to-severe urogenital symptoms
b
Dryness 29 (66%)
Itching 16 (36%)
Soreness 18 (41%)
Pain during sex 18 (41%)
Data are presented as number (percent). Data were missing for 1
participant for education, 3 participants for employment, and 2 partici-
pants for self-reported overall health
aSexual activity status was assessed by using the question, “Are you
currently sexually active with or without a partner?”
bIndicates the number (percentage) of participants who reported a
symptom as being “moderately,”“ quite a bit,” or “extremely” bothersome
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reported being unable to sit for prolonged periods on public
transportation, go for walks, or ride a bicycle because of
dryness/irritation. Participants also described being unable
to go out in public due to a frequent need to retire to a
bathroom to scratch or wipe. Furthermore, some participants
complained that their choice of clothing was limited by their
symptoms, as they could not wear pantyhose or form-fitting
clothing that might irritate the urogenital area.
Women who experienced symptoms specifically during
urination described being reluctant to use the toilet because
of their symptoms: “Well, when I had the dryness, I didn’t want
to drink, because I dreaded the thought of having to urinate,
because I knew it was going to burn.... There was a point there
where I dreaded to have to drink.... I’d hold it, you know,
because it burned so bad.” Women also described elaborate
rituals of washing and wiping in order to relieve their irritation
with urination.
Emotional Wellbeing
Participants varied in the emotions evoked by their symptoms,
with some reporting extreme depression and frustration, and
others being only moderately bothered by this problem (Box 2).
Some women who had not previously heard of urogenital
atrophy indicated that their lack of prior knowledge increased
their emotional distress upon developing symptoms: “Once I...
resumed my sexual activity... I realized that I [had] this
problem, and it was extremely embarrassing and frightening...
I’d gone through so many things, and I’m thinking... I’m going
to be able to enjoy sex... but then... I can’t even have sex, and it
was frightening, and it was disillusioning, and it was frustrat-
ing, and I was really angry.”
Some women reported coping with their symptoms by trying
to ignore their impact on their everyday lives: “I don’t want to
admit that there’s dryness, it’s kind of like, “Oh no, one more
thing,” and I tend to ignore it.... I want to think that I’m not dry,
that those juices are still flowing....” Others complained that
even when they were successful in finding ways of relieving
their symptoms, they felt burdened by constantly having to
think about this problem: “I’ve never been aware of my vagina
at any other time. Suddenly there she is! And I’d rather she’d
be gone most of the time....”
Self-concept and Body Image
In all six focus groups, participants tended to describe their
symptoms as a sign that they were getting old or that their
body was deteriorating (Box 2). As a result, their feelings about
their symptoms often reflected their anxieties and concerns
about growing old. Several women expressed fear or concern
that they were becoming “less of a woman” as a result of these
and other signs of menopause and aging: “You know, what
kind of scared me was, there’s a girlfriend of mine who’s ten
years older than me.... She’s like, ‘Oh, well, you know, as
women age, we become more like men, because [we] don’t have
estrogen,’ and, really, I feel myself getting horrified.... I felt like,
‘Oh my God, I don’t want to get old.’” Others argued that “being
feminine has nothing to do with aging of the vaginal area,” and
insisted that their symptoms, although bothersome, had not
detracted from their sense of womanhood. Several women
complained that their negative feelings about their symptoms
were exacerbated by social pressure to appear or act younger
than their age, including pressure to maintain frequent sexual
activity: “I am thinking if we weren’t faced with this relentless
barrage of ads... and TV shows that are... only about sex and
Table 2. Frequency of Participant Responses Regarding the Impact of Urogenital Symptoms on Dimensions of Functioning and Wellbeing,
by Focus Group
a
White women,
<60 yrs old
White women,
≥60 yrs old
Black women,
<60 yrs old
Black women,
≥60 yrs old
Latina women,
English-speaking
Latina women,
Spanish-speaking
All focus
groups
Sexual functioning—the impact of symptoms on women’s interest in and willingness to engage in sexual activity, ability to enjoy sexual activity, and
ability to maintain sexual or intimate relationships with partners
59 69 33 41 21 45 268
Everyday activities—the extent to which symptoms interfere with participation in activities of daily life, such as dressing, toileting, and exercising, as
well as more complex activities or routines such as working outside the home or recreational activities
9 6 0 15 8 12 50
Emotional wellbeing—the impact of symptoms on mood, including feelings such as depression, anxiety, or frustration, as well as the extent to which
women are preoccupied by their symptoms
15 15 5 14 13 20 82
Self-concept and body image—the extent to which symptoms affect women’s feelings and perceptions about their bodies, their health, and their
identities as women
19 31 2 12 27 22 80
Interpersonal relations—the extent to which symptoms affect women’s ability to socialize with friends and family, their ability to communicate with
others, and their sense of connection to other people in their lives
17 45 9 14 17 45 147
aTranscripts of focus group discussions were independently read and analyzed by three investigators. Each identifiable segment of continuous speech
uttered by a focus group participant was analyzed as a separate unit. Investigators assigned thematic codes to individual speech segments based on
their interpretation of their content; more than one code could be assigned to speech segments that evoked more than one theme. After investigators mett o
resolve any differences in coding, the total number of times that each thematic code appeared in each focus group session was tabulated. Next, thematic
codes were grouped into five overall dimensions of functioning or wellbeing (i.e., sexual functioning, everyday activities, emotional wellbeing, self-concept/
body image, or interpersonal relations), and the total number of times that a thematic code corresponding to each of these dimensions was calculated for
each session.
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happy with our place in society as aging women.”
Interpersonal Relations
Many participants were reluctant to discuss their urogenital
symptoms with their husbands or partners because they were
afraid of being perceived as “too old” or “not good enough” or
being ridiculed for having this problem (Box 2). Some indicated
that they were also uncomfortable with discussing their
symptoms with female friends or relatives, even when they
were accustomed to discussing other types of menopausal
symptoms: “I have four or five very, very close friends.... You
talk about the flashes, you talk about the fact that, OK, maybe
you haven’t had sexual activity in a couple of weeks.... But as
far as [dryness] is concerned, we never talk about that.”
Because they had not discussed these symptoms with others,
some participants said that they mistakenly believed that they
alone had this problem: “When I got all of this, I was ignorant. I
didn’t know that I would get dryness, itching, irritations.... I
didn’t know! And I put up with it for a long time, until very
recently when I told my doctor.... Could it just be me, could it
be that it’s not everyone?”
Participants also reported being reluctant to discuss their
symptoms with health care providers, even when their symp-
toms significantly affected their quality of life: “I started to get
these things like dryness, itchiness, irritation that was very
bothersome. Sometimes when I scratched myself, even with a
towel, I would bleed. But I was scared. Even with all that I
wasn’t brave enough to tell my doctor.” Some women indicated
that they were not aware that their symptoms could be caused
by a medical problem until they were finally evaluated by a
doctor: “I felt really isolated for a long time, because I didn’t
understand that this could happen. And the first time I
became aware of it, I was having an exam at the doctor’s
office.... [T]hey’re looking in there, and she said, ‘You see that,
that’s urogenital atrophy,’ and I went, ‘Oh!’”
Beliefs About Etiology
Some participants attributed their symptoms to modifiable
behaviors such as physical exercise or fluid intake, while
others regarded their symptoms to be an unavoidable conse-
quence of aging or menopause: “You get to be 65, your whole
body dries up.... [M]y ears is dry, my nose is dry, my eyes is dry,
my everything is dry.” Women also expressed concerns that
their symptoms were caused or exacerbated by their prior use
of hormone-based therapies: “So I also felt a little punished....
Well, if you had been smarter... not taken birth control pills,
maybe you wouldn’t have this problem right now...” Other
women believed that they had developed urogenital dryness as
a side effect of other medications: “And when we get older we
do take a lot of medicine.... Anybody taking some kind of pill
even if it’s only an aspirin a day... that aspirin could be sucking
up all the water in the body.”
Women also expressed conflicting views about the role of
sexual activity in the etiology of their symptoms, with some
believing that women who remained sexually active were less
likely to be symptomatic, and others believing that sexual
activity could worsen symptoms. Several expressed concern
that their symptoms resulted from contracting a sexually
transmitted disease: “Yes, I thought, I would say, ‘Who knows
where this man has gone and who knows what he’s given me,’
because after having sex with him, I would feel that terrible
burning....” Participants also expressed concern that they had
developed symptoms as a result of poor hygiene: “It’s just like,
are you cleaning up down there? Or, you know, is it dirty in
there? So... you’re putting water in the sink, and putting soap
in there, and you’re scrubbing and scrubbing.”
Treatment/Coping Strategies
Participants described a variety of approaches to managing
their symptoms, including hormone therapies, non-hormonal
lubricants and moisturizers, alternative/complementary ther-
apies, and washing and soaking techniques. Concern about
the potential side effects of estrogen-based therapies emerged
in all groups: “I just don’t like to put all that stuff in my body,
because... five or six years from now, you’ve got vaginal cancer
or something.” However, some participants argued that the
relief they obtained with these therapies was worth the risks:
“It’s been about two years [since] I was taken off the hormone
therapy, and I was getting up every night, at least three times...
and dealing with dryness. So I did go back to the doctor and
ask to be put back on it... And at my age, it’s more important
about the quality of my life than how long I live.” Frustration
about the inadequacy of existing treatments emerged in all
focus groups, with women complaining that fewer treatments
were available for problems related to women’s sexual function
than men’s: “[W]hen men begin to have difficulties, well here is
Viagra... like the perfect solution... not quite realizing that
maybe there isn’t as perfect a solution as Viagra to our
problem.”
DISCUSSION
In this study of racially/ethnically diverse postmenopausal
women, we found that urogenital symptoms such as dryness,
soreness, itching, and pain/discomfort with sexual intercourse
had a profound and multi-layered impact on day-to-day
functioning and wellbeing. For some, urogenital symptoms
primarily affected their ability to have and enjoy sex, as well as
their ability to be responsive to their partners. For others,
symptoms restricted their choice of clothing, interfered with
exercising or toileting, and limited their ability to go out in
public. Participants from all age and racial/ethnic groups
reported feelings of depression, frustration, or anxiety related
to their symptoms, although some were more successful in
coping than others. Many regarded their symptoms as a
palpable sign that they were getting old or that their body
was deteriorating; some also associated their symptoms with a
loss of womanhood or femininity. Additionally, many described
feelings of isolation or embarrassment due to a belief that they
alone suffered from this problem.
Several limitations of this research should be acknowledged.
First, we purposefully recruited women with moderate-to-
severe urogenital symptoms to participate in our study. Our
findings may not be generalizable to women with milder
symptoms, who might be less likely to believe they had a
problem worthy of discussion. Second, we did not require
women to undergo clinical evaluation for their symptoms, and
it is possible that some participants suffered from diseases
other than menopause- or age-related urogenital atrophy.
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of urogenital dryness, soreness, itching, and dyspareunia in
postmenopausal women independent of etiology.
Several of our findings may be important to the evaluation
and/or management of urogenital symptoms in older women.
Many of our participants indicated they were uncomfortable
seeking treatment, even when their symptoms significantly
compromised their quality of life. Our findings suggest that
clinicians may need to question older women actively about
urogenital symptoms and initiate discussion of strategies for
reducing their burden on women’s day-to-day lives, rather
than waiting for women to volunteer information about this
problem.
Additionally, participants’ subjective experiences of and
responses to their symptoms were influenced by their percep-
tion of what constituted “normal” urogenital function after
menopause, as well as their beliefs about the underlying cause
of their symptoms. These findings underline the need for
clinicians to address women’s understanding of the etiology
of their symptoms, including any misconceptions about the
contribution of medications, hygiene, and sexual activity that
may magnify the impact of symptoms on self-image and
emotional wellbeing.
Third, the impact of symptoms on participants’ sexual
functioning varied markedly depending on whether women
had a sexual partner, the nature of their relationship to that
partner, and whether the partner also had physical or sexual
problems. Women who felt that their partners were unable or
unwilling to accommodate their symptoms appeared especially
likely to feel that their sexual lives were compromised. These
findings underline the need for clinicians to address the larger
context of women’s sexual relationships when counseling them
about urogenital atrophy, as well as to tailor discussion of
different types of therapies (e.g., daily maintenance therapy with
a vaginal moisturizer versus use of a lubricant before inter-
course) to women’s priorities regarding their sexual functioning.
Finally, many participants expressed conflicting feelings
about using treatments such as estrogen that could improve
their symptoms but might be associated with other health
problems. For women with severe or disruptive symptoms,
clinicians may play a useful role in helping women to
thoughtfully weigh the risks and benefits of estrogen-based
treatments for urogenital atrophy.
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